Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C32H48BF5O4S |
| Molecular Weight | 634.589 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)CC4=CC(=CC=C34)B(O)O
InChI
InChIKey=FIAYIYKWRBIBQG-GDWZZRAASA-N
InChI=1S/C32H48BF5O4S/c1-30-17-15-26-25-12-11-24(33(40)41)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-43(42)19-9-16-31(34,35)32(36,37)38/h11-12,21-22,26-29,39-41H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,43?/m1/s1
| Molecular Formula | C32H48BF5O4S |
| Molecular Weight | 634.589 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:35:28 GMT 2025
by
admin
on
Wed Apr 02 08:35:28 GMT 2025
|
| Record UNII |
E35ZN95LMT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
E35ZN95LMT
Created by
admin on Wed Apr 02 08:35:28 GMT 2025 , Edited by admin on Wed Apr 02 08:35:28 GMT 2025
|
PRIMARY | |||
|
ZB716
Created by
admin on Wed Apr 02 08:35:28 GMT 2025 , Edited by admin on Wed Apr 02 08:35:28 GMT 2025
|
PRIMARY | |||
|
1853279-29-4
Created by
admin on Wed Apr 02 08:35:28 GMT 2025 , Edited by admin on Wed Apr 02 08:35:28 GMT 2025
|
PRIMARY | |||
|
300000052837
Created by
admin on Wed Apr 02 08:35:28 GMT 2025 , Edited by admin on Wed Apr 02 08:35:28 GMT 2025
|
PRIMARY | |||
|
DTXSID601107524
Created by
admin on Wed Apr 02 08:35:28 GMT 2025 , Edited by admin on Wed Apr 02 08:35:28 GMT 2025
|
PRIMARY | |||
|
126480615
Created by
admin on Wed Apr 02 08:35:28 GMT 2025 , Edited by admin on Wed Apr 02 08:35:28 GMT 2025
|
PRIMARY | |||
|
C179265
Created by
admin on Wed Apr 02 08:35:28 GMT 2025 , Edited by admin on Wed Apr 02 08:35:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
In vitro and in vivo pharmacological studies of ZB716 demonstrate it is a pure antagonist of the
ER. It binds to the ER and degrades the protein in a dose-dependent manner.
IN-VITRO, IN-VIVO
|
||
|
TARGET->DEGRADER |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|